Open | - |
Close | - |
Volume / Avg. | 0 / 54.229K |
Day Range | - - - |
52 Wk Range | 36.120 - 51.037 |
Market Cap | $562.102M |
P/E Ratio | 32.881 |
Dividend Yield | 0.340% |
Exchange | NASDAQ |
RSI | 54 |
Short Interest | 1.31% |
Days to Cover | 1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of iRadimed (NASDAQ: IRMD) through any online brokerage.
Other companies in iRadimed’s space includes: NeuroPace (NASDAQ:NPCE), Axogen (NASDAQ:AXGN), SI-BONE (NASDAQ:SIBN), Varex Imaging (NASDAQ:VREX) and Fractyl Health (NASDAQ:GUTS).
The latest price target for iRadimed (NASDAQ: IRMD) was reported by Roth Capital on Monday, August 2, 2021. The analyst firm set a price target for 36.00 expecting IRMD to fall to within 12 months (a possible -18.90% downside). 0 analyst firms have reported ratings in the last year.
The stock price for iRadimed (NASDAQ: IRMD) is $44.39 last updated March 18, 2024 at 4:00 PM EDT.
A quarterly cash dividend of $0.15 per share of Class A Common Stock. The quarterly cash dividend was payable on January 12, 2024 to stockholders of record on December 21, 2023.
iRadimed’s Q1 earnings are confirmed for Thursday, May 2, 2024.
There is no upcoming split for iRadimed.
iRadimed is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NASDAQ.